STOCK WARRANTS, STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details 4) - Restricted Stock Units [Member] - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Unvested begenning | 133,585 | 71,667 |
Granted | 41,667 | |
Unvested ending | 175,252 | 71,667 |
Weighted Average Vesting Period, beginning balance | 11 months 19 days | 8 years 9 months |
Weighted Average Vesting Period RSU granted | 1 year 4 days | 0 years |
Weighted Average Vesting Period, ending balance | 8 months 26 days | 1 year 3 days |
Weighted Average Grant Date Fair Value Per Share beginning balance | $ 8.56 | $ 8.75 |
Weighted Average Grant Date Fair Value Per Share RSU granted | 6.92 | |
Weighted Average Grant Date Fair Value Per Share ending balance | $ 8.17 | $ 8.75 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|